POEMS syndrome history and symptoms: Difference between revisions

Jump to navigation Jump to search
 
(6 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{POEMS syndrome}}
{{POEMS syndrome}}
{{CMG}}
{{CMG}} {{AE}} {{HK}}


== Overview ==
== Overview ==
Patients suffering from POEMS syndrome may have variable presentation and can present a diagnostic challenge for the clinician due to non-specific symtoms. Common symtoms of POEMS syndrome include numbness, tingling and weakness affecting extremities, fatigue, generalized pain in the body, foot drop, blurred vision, peripheral edema, dyspnea and hyperpigmentation. Less common symptoms include muscle weakness, diplopia, ocular pain and ascites.  
Patients suffering from POEMS syndrome may have variable presentation and can present a diagnostic challenge for the clinician due to non-specific symptomology. Common [[symptoms]] of POEMS syndrome include [[numbness]], [[Paresthesia|tingling]] and weakness affecting extremities, [[fatigue]], generalized pain in the body, [[foot drop]], [[blurred vision]], [[peripheral edema]], [[dyspnea]] and [[hyperpigmentation]]. Less common [[symptoms]] include [[muscle weakness]], [[diplopia]], [[ocular]] pain and [[ascites]].  


== History ==
== History and Symptoms ==
Patients suffering from POEMS syndrome may have variable clinical presentations due to multi-system involvement. The median time from onset of symptoms to diagnosis of POEMS is 13 to 18 months. Presence of a combination of peripheral neuropathy, and monoclonal protein, particularly a lambda-restricted monoclonal gammopathy should raise the suspicion of POEMS syndrome.


==Symptoms==
=== History ===
Patients suffering from POEMS syndrome may have variable presentation and can present a diagnostic challenge for the clinician.  
 
* [[Patient|Patients]] suffering from POEMS syndrome may have variable clinical presentations due to multi-system involvement.
* The [[median]] time from onset of [[symptoms]] to [[diagnosis]] of POEMS is 13 to 18 months.<ref name="pmid12456500">{{cite journal |vauthors=Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA |title=POEMS syndrome: definitions and long-term outcome |journal=Blood |volume=101 |issue=7 |pages=2496–506 |date=April 2003 |pmid=12456500 |doi=10.1182/blood-2002-07-2299 |url=}}</ref><ref name="pmid21221584">{{cite journal |vauthors=Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T |title=Clinical characteristics and long-term outcome of patients with POEMS syndrome in China |journal=Ann. Hematol. |volume=90 |issue=7 |pages=819–26 |date=July 2011 |pmid=21221584 |doi=10.1007/s00277-010-1149-0 |url=}}</ref>
* Presence of a combination of [[peripheral neuropathy]], and [[Monoclonal gammopathy|monoclonal]] protein, particularly a lambda-restricted [[monoclonal gammopathy]] should raise the suspicion of POEMS syndrome.


=== Common Symptoms ===
=== Common Symptoms ===
Common symptoms of POEMS syndrome include the following:<ref name="pmid24532337">{{cite journal |vauthors=Dispenzieri A |title=POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management |journal=Am. J. Hematol. |volume=89 |issue=2 |pages=214–23 |date=February 2014 |pmid=24532337 |doi=10.1002/ajh.23644 |url=}}</ref><ref name="pmid24624542">{{cite journal |vauthors=Dispenzieri A, Buadi FK |title=A review of POEMS syndrome |journal=Oncology (Williston Park, N.Y.) |volume=27 |issue=12 |pages=1242–50 |date=December 2013 |pmid=24624542 |doi= |url=}}</ref>
Common [[symptoms]] of POEMS syndrome include the following:<ref name="pmid24532337">{{cite journal |vauthors=Dispenzieri A |title=POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management |journal=Am. J. Hematol. |volume=89 |issue=2 |pages=214–23 |date=February 2014 |pmid=24532337 |doi=10.1002/ajh.23644 |url=}}</ref><ref name="pmid24624542">{{cite journal |vauthors=Dispenzieri A, Buadi FK |title=A review of POEMS syndrome |journal=Oncology (Williston Park, N.Y.) |volume=27 |issue=12 |pages=1242–50 |date=December 2013 |pmid=24624542 |doi= |url=}}</ref><ref name="pmid23811954">{{cite journal |vauthors=Cui RT, Yu SY, Huang XS, Zhang JT, Li F, Pu CQ |title=The characteristics of ascites in patients with POEMS syndrome |journal=Ann. Hematol. |volume=92 |issue=12 |pages=1661–4 |date=December 2013 |pmid=23811954 |doi=10.1007/s00277-013-1829-7 |url=}}</ref><ref name="pmid6248720">{{cite journal |vauthors=Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL |title=Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature |journal=Medicine (Baltimore) |volume=59 |issue=4 |pages=311–22 |date=July 1980 |pmid=6248720 |doi= |url=}}</ref><ref name="pmid23557151">{{cite journal |vauthors=Miest RY, Comfere NI, Dispenzieri A, Lohse CM, el-Azhary RA |title=Cutaneous manifestations in patients with POEMS syndrome |journal=Int. J. Dermatol. |volume=52 |issue=11 |pages=1349–56 |date=November 2013 |pmid=23557151 |doi=10.1111/j.1365-4632.2012.05648.x |url=}}</ref><ref name="pmid24141729">{{cite journal |vauthors=Cui R, Yu S, Huang X, Zhang J, Tian C, Pu C |title=Papilloedema is an independent prognostic factor for POEMS syndrome |journal=J. Neurol. |volume=261 |issue=1 |pages=60–5 |date=January 2014 |pmid=24141729 |doi=10.1007/s00415-013-7143-4 |url=}}</ref>
* Numbness, tingling and weakness in the feet, later affecting the legs and hands
* [[Numbness]], [[tingling]] and weakness in the feet, later affecting the legs and hands
* Fatigue
* [[Fatigue]]
*  Generalized pain  
*  Generalized pain  
*  Foot drop
[[Foot drop]]
* Blurred vision
* [[Blurred vision]]
* Peripheral edema
* [[Peripheral edema]]
* Dyspnea
* [[Dyspnea]]
* Hyperpigmentation
* [[Hyperpigmentation]]
* [[Clubbing]]


=== Less Common Symptoms ===
=== Less Common Symptoms ===
Less common symtoms of POEMS syndrome include the following:
Less common [[symptoms]] of POEMS syndrome include the following:<ref name="pmid7985714">{{cite journal |vauthors=Soubrier MJ, Dubost JJ, Sauvezie BJ |title=POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome |journal=Am. J. Med. |volume=97 |issue=6 |pages=543–53 |date=December 1994 |pmid=7985714 |doi= |url=}}</ref><ref name="urlPOEMS Syndrome - NORD (National Organization for Rare Disorders)">{{cite web |url=https://rarediseases.org/rare-diseases/poems-syndrome/ |title=POEMS Syndrome - NORD (National Organization for Rare Disorders) |format= |work= |accessdate=}}</ref>
* Muscle weakness
* [[Muscle weakness]]
* Diplopia
* [[Diplopia]]
* Ocular pain
* [[Ocular]] pain
* Ascites
* [[Ascites]]
* Erectile dysfunction  
* [[Erectile dysfunction]]
* [[Gynecomastia]]
* [[Amenorrhea]]


==References==
==References==

Latest revision as of 14:02, 9 August 2019

POEMS syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating POEMS syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

POEMS syndrome history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of POEMS syndrome history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on POEMS syndrome history and symptoms

CDC on POEMS syndrome history and symptoms

POEMS syndrome history and symptoms in the news

Blogs on POEMS syndrome history and symptoms

Directions to Hospitals Treating POEMS syndrome

Risk calculators and risk factors for POEMS syndrome history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Patients suffering from POEMS syndrome may have variable presentation and can present a diagnostic challenge for the clinician due to non-specific symptomology. Common symptoms of POEMS syndrome include numbness, tingling and weakness affecting extremities, fatigue, generalized pain in the body, foot drop, blurred vision, peripheral edema, dyspnea and hyperpigmentation. Less common symptoms include muscle weakness, diplopia, ocular pain and ascites.

History and Symptoms

History

Common Symptoms

Common symptoms of POEMS syndrome include the following:[3][4][5][6][7][8]

Less Common Symptoms

Less common symptoms of POEMS syndrome include the following:[9][10]

References

  1. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA (April 2003). "POEMS syndrome: definitions and long-term outcome". Blood. 101 (7): 2496–506. doi:10.1182/blood-2002-07-2299. PMID 12456500.
  2. Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T (July 2011). "Clinical characteristics and long-term outcome of patients with POEMS syndrome in China". Ann. Hematol. 90 (7): 819–26. doi:10.1007/s00277-010-1149-0. PMID 21221584.
  3. Dispenzieri A (February 2014). "POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 89 (2): 214–23. doi:10.1002/ajh.23644. PMID 24532337.
  4. Dispenzieri A, Buadi FK (December 2013). "A review of POEMS syndrome". Oncology (Williston Park, N.Y.). 27 (12): 1242–50. PMID 24624542.
  5. Cui RT, Yu SY, Huang XS, Zhang JT, Li F, Pu CQ (December 2013). "The characteristics of ascites in patients with POEMS syndrome". Ann. Hematol. 92 (12): 1661–4. doi:10.1007/s00277-013-1829-7. PMID 23811954.
  6. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (July 1980). "Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature". Medicine (Baltimore). 59 (4): 311–22. PMID 6248720.
  7. Miest RY, Comfere NI, Dispenzieri A, Lohse CM, el-Azhary RA (November 2013). "Cutaneous manifestations in patients with POEMS syndrome". Int. J. Dermatol. 52 (11): 1349–56. doi:10.1111/j.1365-4632.2012.05648.x. PMID 23557151.
  8. Cui R, Yu S, Huang X, Zhang J, Tian C, Pu C (January 2014). "Papilloedema is an independent prognostic factor for POEMS syndrome". J. Neurol. 261 (1): 60–5. doi:10.1007/s00415-013-7143-4. PMID 24141729.
  9. Soubrier MJ, Dubost JJ, Sauvezie BJ (December 1994). "POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome". Am. J. Med. 97 (6): 543–53. PMID 7985714.
  10. "POEMS Syndrome - NORD (National Organization for Rare Disorders)".

Template:WikiDoc Sources